StockGuru Spotlight on Relmada Therapeutics, Inc.
(Symbol: RLMD)

Help us update information on this company. Email any updates to: [email protected]

About Relmada Therapeutics, Inc.:

We are a clinical stage, public specialty pharmaceutical company, focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain.

 

Where it is located:

546 Fifth Avenue
14th Floor

New York, NY
10036

United States

 

Key Executive Contact:

Douglas Beck

CFO

 

Ninety Day Volume:

28262 (as of date of publication)

 

Ninety Day Dollar Volume:

$77,184

 

Share Information:

40301717 shares as of 2014-09-02

 

Corporate Information:

State Incorporated: NV

Country Incorporated: USA

 

Contact, Website and Social Media for Relmada Therapeutics, Inc.:

Shown Where Available

Website: http://www.relmada.com

Facebook:

Twitter:

LinkedIn:

Telephone: (212) 702-7163

Email: [email protected]

 

 

Investor Relations for Relmada Therapeutics, Inc.: